jim schultz md mba faafp dimm fawm chief medical officer
play

Jim Schultz, MD, MBA, FAAFP, DiMM, FAWM Chief Medical Officer - PowerPoint PPT Presentation

Hypertension Control and Undiagnosed Hypertension in a Pandemic: One Community Health Centers Approach Jim Schultz, MD, MBA, FAAFP, DiMM, FAWM Chief Medical Officer Neighborhood Healthcare RightCare, August 26, 2020 Phimai Temple, Isan area


  1. Hypertension Control and Undiagnosed Hypertension in a Pandemic: One Community Health Center’s Approach Jim Schultz, MD, MBA, FAAFP, DiMM, FAWM Chief Medical Officer Neighborhood Healthcare RightCare, August 26, 2020 Phimai Temple, Isan area of Thailand, Jan 28, 2020

  2. Goals and Objectives: • Discuss One CHC’s HTN control efforts and how these have changed in a Covid pandemic • Elevate awareness of the problem of undiagnosed hypertension • Describe ways to determine the rate of undiagnosed hypertension in a medical practice setting • Describe resources for and practical methods of reducing undiagnosed hypertension in a medical practice setting

  3. This is a Test! 1.How many people in the US have undiagnosed hypertension? A. 2 million B. 5.4 million C. 12 million D. way more now than before March 2020

  4. This is a Test! 2. How do I know if I have hypertension patients hiding in plain sight? A. use the CDC Million Hearts Hypertension Prevalence Estimator B. use my registry to run a report C. A and B D. I don’t have any at all!

  5. This is a Test! 3. What is the most common reason for hypertension going untreated in our active patients? A. lack of insurance coverage B. not going to the doctor C. no primary care physician D. clinical neglect E. inefficient clinical systems

  6. This is a Test! 4. What is the best way to rapidly improve your group’s HEDIS hypertension control rate? A. improve BP measuring technique B. reduce clinical inertia by use of treatment guidelines or protocols C. entering home BP readings into the BP field in your EMR D. all of the above E. A and B

  7. This is a Test! 5. How can you reduce mortality and morbidity related to undiagnosed hypertension? A. P re-visit planning/proactive office encounters B. P romiscuous use of a registry C. P oint-of-care real time reporting D. P rayer E. All of the above

  8. Neighborhood Healthcare: 2020 stats: 16 sites/2 counties 74,000 patients 307,000+ visits 24,000 BH only visits 21,000 Pediatric pts $90+M budget ~58 FTE medical providers 7.5 FTE Dentists (3 NHCare sites) 3 FTE PharmD 26+ FTE BH Contracted Medical/Dental 16 primary care sites, all PCMH-3 accredited (all with embedded BH) Board of Directors: >50% patients

  9. Neighborhood Healthcare: ● Full range of Primary Care ● Prenatal care ● Psychiatric care, including child, SMI, tele-psych ● Embedded BH in all primary care sites ● Medication Assisted Addiction Therapy ● PharmD/MD-led MTM ● Retinopathy Screening Program-tele med ● Dental, Podiatry, Chiropractic and Acupuncture ● Intensive Diabetes and rapid control program ● Extended Hours ● Retail clinic ● Embedded medical clinic in Interfaith Services (social services agency/shelter/soup kitchen)

  10. Neighborhood Healthcare • Monthly visits at NHCare : • ~1400-1500 visits/day • 20,000 Primary Care • 2000 psychiatric/BH (24,000/yr) • 1200 dental (14,400/yr) • >5000 ‘walk ins’ • (60,000 ER visits/yr avoided) • ~15% unfunded/uninsured • ~80% MediCal

  11. Neighborhood Healthcare: FQHC Payment Model PPS rate: $X per visit with clinicians with certain licenses: ● MD/DO, PA, NP, PhD, Dentist, Chiro, Acupuncturist, Optometrist, LCSW, ?MFT ● scope of service limitations ● OSHPD3 requirements ● see all without regards to ability to pay ● Coding/complexity doesn’t change reimbursement NO reimbursement for : ● PharmD, Health Coach, RN, PT, OT, ST, RT, Patient Navigator, Outreach Worker, etc.

  12. NHCare BP Control Results 3 year trend Peak 80% 8 month trend- 2020 Current: 72% N~12,000

  13. NHCare DM BP Control Results 3 year trend Peak: 81% 8 month trend- 2020 Current: 75% N~6400

  14. NHCare BP Control Disparities Analysis

  15. NHCare BP Control - Methods • Data at point of care • Quality emphasis- DM, HTN, CA screening • reporting • Pt engagement • MA/staff training- motivational interviewing • Hiring practices • Leadership commitment and accountability • Use of non-MD staff • BH/SDoH/holistic emphasis

  16. Data at the ‘Right’ Time - Alerts ‘app’

  17. Data at the Point of Care: Registry, ‘alerts app’ Real time data • Actionable (click red to • order) Verifiable (eg ASCVD • risk) Task completion (click • red to enter chart info) Relevant to MD • Transparent •

  18. Data at the Point of Care: Registry, ‘alerts app’

  19. Data at the Point of Care: Registry, ‘alerts app’

  20. Hiding in Plain Sight (HIPS)

  21. Hiding in Plain Sight (HIPS) Nov 19, 2014 Vol 312, Number 19

  22. Hypertension Stats- US • Hypertension: • 29% prevalence among US adults (2011-2012) • 33% among adults 40-59 • 65% among adults 60+ • 42% among non-Hispanic blacks • Up to 40% of HTN patients are NOT diagnosed • ~67-71M adults have hypertension Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination ○ Survey, 2011 – 2012. NCHS data brief, no 133. Hyattsville, MD: National Center for Health Statistics. 2013. Valderrama AL, Gillespie C, King SC, George MG, Hong Y, Gregg E. Vital signs: awareness and treatment of uncontrolled ○ ypertension among adults — United States, 2003 – 2010. MMWR . 2012;61:703-709. Slide courtesy of CDC ○

  23. Hypertension- Treatment Impact • Impact of Hypertension: Normal BP: Life 5 years longer • • Reduction in BP by 5mmHg: stroke risk by 34% • ischemic heart dz by 21% • • Antihypertensive Rx associated • with: 35-40% stroke risk • 20-25% heart attack risk • >50% CHF • 1.Franco OH, PeetersA, BonneuxL, de LaetC. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: Life course analysis. Hypertension . 2005;46:280. 2.Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health TechnolAssess. 2003;7(31):1-94 3.ChobanianAV, BakrisGL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.

  24. Hiding in Plain Sight (HIPS) ○ 34M US Adults with uncontrolled HTN Aware and treated Aware and untreated "Unaware" 14.1 16 5.7 Slide courtesy of CDC

  25. Hiding in Plain Sight (HIPS) • Why undiagnosed? • No insurance? 81.8% have health insurance • • No PCP? 82.5% report having a usual source of care • • Don’t go to the MD? 61.7% have received care two or more times in the • past year Wall HK, Hannan JA, Wright JS. Patients with Undiagnosed Hypertension: Hiding in Plain Sight. JAMA. 2014;312(19):1973-74 . ○

  26. HIPS JAMA conclusion: Recommendations : • Assess practice data • Develop systematic approach to identify potentially undiagnosed hypertensives • Estimate HTN prevalence, use to track ‘The nation can and must improve hypertension control to reduce preventable myocardial infarctions and stroke…improvement can only occur if all patients with hypertension are promptly identified, accurately diagnosed, and provided with evidence- based treatment and support.’

  27. HTN Control Rates- Your control rate may be wrong! • Math!:‘BP Control rates’: • Typical calculation methodology: • denominator: ‘search for ICD code 401.x or I10’ • numerator: ‘last SBP < 140 AND last DBP <90’ NQF Measure 18 Data Definition

  28. Your control rate may be wrong! • Math! Example • 1000 patient with dx of 401.x or I10 • 750 meet numerator criteria (<140 and < 90) • 75%- pretty good! • What if you have 500 undiagnosed patients? • Denominator changes to 1500 Control rate changes to 750/(1000+500)= • 750/1500= 50%

  29. Hiding in Plain Site at Geisinger • Used data from 400K+ adult outpatients to ID patients with HTN 1. The problem list 2. ICD-9 diagnosis 3. Antihypertensive medications Rx 4. Two elevated BP values based on JNC-7 criteria 2 systolic measures ≥140 or 2 diastolic measures ≥90 • Found 106K patients with one or more criteria 30% based solely on #4 (i.e. undiagnosed) • HTN Prevalence – ~18.6% vs ~26.5% • Shah NR. Identifying hypertension in electronic health records: a comparison of various approaches. Paper presented at: AHRQ ○ Comparative Effectiveness Research Methods Symposium; June 2009; Rockville, MD. Of Various Approaches. AHRQ Comparative Effectiveness Research Methods Symposium, Rockville, MD, June 2009.

  30. H IDING IN P LAIN S IGHT AT P ALO A LTO M EDICAL F OUNDATION • 250,000 adult patients 2006 - 2008 • For patients with ≥ 2 BP readings of 140/90 or higher, an antihypertensive medication prescription, or both, 37.1% did not have an ICD-9-CM code • HTN prevalence went from 18.0% to 28.7% • And: Much more likely to be on an antihypertensive • with a HTN diagnosis 92.6% diagnosed vs 15.8% undiagnosed, P < .001 • Banerjee D, Chung S, Wong EC, Wang EJ, Stafford RS, Palaniappan LP. Underdiagnosis of hypertension using electronic ○ health records. Am J Hypertens . 2012;25(1):97-102.

Recommend


More recommend